Screener
PBE vs QQQJ
Invesco Biotechnology & Genome ETF vs Invesco NASDAQ Next Gen 100 ETF
Key differences
- QQQJ costs 0.43% less per year.
- QQQJ is significantly larger than PBE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, QQQJ has delivered higher annualized returns.
- PBE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PBE | QQQJ | |
|---|---|---|
| Annual cost (TER) | 0.58% | 0.15% |
| Fund size (AUM) | $247M | $954M |
| Since | 2005 | 2020 |
| Dividend yield | 1.09% | 0.81% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +35.8% | +45.1% |
| CAGR 3Y | +10.3% | +21.6% |
| CAGR 5Y | +3.5% | +7.9% |
| Sharpe 3Y | 0.41 | 0.96 |
| Volatility 1Y | 18.63% | 18.08% |
| Max drawdown | -37.84% | -39.58% |
Similar to PBE and QQQJ
Explore further